France has reaffirmed its nuclear strategy, backing EPR2 reactors, fuel cycle investments, and next-gen technologies to ...

CRE Devco Germantown is weighing its options on how to move forward with The Standard Germantown development after a TIF was ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 million ...

The Seattle City Council’s Select Committee on the Comprehensive Plan will hold its first meeting of the year Thursday as it kicks off what officials are calling “Phase II” of ...

With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, Inc.'s CMO ...

Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.

China Everbright Environment Group Limited ("Everbright Environment" or the "Company") (257.HK) announces the consolidated results of the Company and its subsidiaries (collectively the "Group") for ...

With its emergency shelter beds frequently running at 50 per cent over capacity and demand so great that it's forced to refer ...

KELLOGG, Idaho and VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. ("Bunker Hill" or the "Company") (TSX-V: BNKR | OTCQB: BHLL), is pleased to provide an updat ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate (cORR) of 52% in serous endometrial cancer (EC) ...